ATE82134T1 - Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens. - Google Patents

Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.

Info

Publication number
ATE82134T1
ATE82134T1 AT88401996T AT88401996T ATE82134T1 AT E82134 T1 ATE82134 T1 AT E82134T1 AT 88401996 T AT88401996 T AT 88401996T AT 88401996 T AT88401996 T AT 88401996T AT E82134 T1 ATE82134 T1 AT E82134T1
Authority
AT
Austria
Prior art keywords
polyosides
strains
staphylococcus
capsules
recovering
Prior art date
Application number
AT88401996T
Other languages
German (de)
English (en)
Inventor
Jean-Michel Fournier
Anne Bouvet
Alain Boutonnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE82134T1 publication Critical patent/ATE82134T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y10S435/883—Staphylococcus aureus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88401996T 1987-08-03 1988-07-29 Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens. ATE82134T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8711006A FR2619122B1 (fr) 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
EP88401996A EP0302781B1 (fr) 1987-08-03 1988-07-29 Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé

Publications (1)

Publication Number Publication Date
ATE82134T1 true ATE82134T1 (de) 1992-11-15

Family

ID=9353830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88401996T ATE82134T1 (de) 1987-08-03 1988-07-29 Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.

Country Status (11)

Country Link
US (1) US4902616A (enExample)
EP (1) EP0302781B1 (enExample)
JP (1) JPH01128793A (enExample)
AT (1) ATE82134T1 (enExample)
CA (1) CA1320466C (enExample)
DE (1) DE3875850T2 (enExample)
DK (1) DK173564B1 (enExample)
ES (1) ES2052759T3 (enExample)
FR (1) FR2619122B1 (enExample)
GR (1) GR3006613T3 (enExample)
PT (1) PT88166B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
GB8906794D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Preparation of vaccines
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
AU681573B2 (en) * 1991-11-22 1997-09-04 Glaxosmithkline Biologicals Sa Type I and type II surface antigens associated with (staphylococcus epidermidis)
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US5837482A (en) * 1997-01-23 1998-11-17 Minnesota Mining And Manufacturing Company Culture medium and methods for detecting staphylococci
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
EP1967203A1 (en) * 1998-07-15 2008-09-10 The Brigham and Women's Hospital Polysaccharide vaccine for staphylococcal infections
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
US6936258B1 (en) * 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7119172B2 (en) * 2001-05-21 2006-10-10 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US6962813B2 (en) * 2001-05-21 2005-11-08 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US7723087B2 (en) 2002-11-12 2010-05-25 The Brigham And Women's Hospital, Inc. Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
PT1565478T (pt) 2002-11-12 2017-11-14 The Brigham And Women`S Hospital Inc Vacina de polissacáridos para infeções estafilocócicas
CN1922489A (zh) * 2003-12-30 2007-02-28 3M创新有限公司 葡萄球菌的检测
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
JP5080243B2 (ja) 2004-04-21 2012-11-21 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド ポリ−Ｎ−アセチルグルコサミン（ＰＮＡＧ／ｄＰＮＡＧ）結合ペプチドおよびその使用方法
AU2005286694A1 (en) * 2004-09-21 2006-03-30 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
JP5658564B2 (ja) * 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
KR101573648B1 (ko) 2008-07-21 2015-12-01 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
HUE026855T2 (en) 2009-04-03 2016-07-28 Univ Chicago Compositions and methods related to protein a (spa) variants
SG186290A1 (en) 2010-07-02 2013-01-30 Univ Chicago Compositions and methods related to protein a (spa) variants
BR112013024322B1 (pt) * 2011-03-22 2020-04-22 Serum Inst India Ltd processo para preparação de polissacarídeos
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Also Published As

Publication number Publication date
EP0302781B1 (fr) 1992-11-11
JPH01128793A (ja) 1989-05-22
US4902616A (en) 1990-02-20
DK173564B1 (da) 2001-03-12
PT88166B (pt) 1995-07-03
FR2619122B1 (fr) 1990-03-09
DE3875850D1 (de) 1992-12-17
DE3875850T2 (de) 1993-06-09
GR3006613T3 (enExample) 1993-06-30
FR2619122A1 (fr) 1989-02-10
EP0302781A1 (fr) 1989-02-08
PT88166A (pt) 1989-06-30
ES2052759T3 (es) 1994-07-16
DK433488A (da) 1989-02-04
CA1320466C (en) 1993-07-20
DK433488D0 (da) 1988-08-03

Similar Documents

Publication Publication Date Title
ATE82134T1 (de) Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.
NL189128C (nl) Werkwijze voor de bereiding van 1,2,4-triazoolverbindingen, werkwijze voor de bereiding van preparaten voor de bestrijding van fungi die deze verbindingen bevatten, alsmede werkwijze voor het bestrijden van planteziekten.
DE3887232D1 (de) Verfahren zur Herstellung von Bildsensorbauelementen, die zu Modulen zusammengesetzt werden.
IT1193874B (it) Procedimento per la preparazione di una miscela polimerica,prodotti formati e lega polimerica ottenuti da essa
IT7826758A0 (it) Microorganismi e procedimento per nuove preparazioni dila loro produzione, come pure l'impiego delle stesse per la decomposizione di prodotti industriali organici di sintesi.
NL7903400A (nl) Werkwijze voor de bereiding van alpha,beta-onverzadigde n-gesubstitueerde carbonzuuramiden.
ES498476A0 (es) Procedimiento de preparacion de arn ribosomales bacterianos
EP0329008A3 (de) Cephalosporinderivative und Verfahren zu ihrer Herstellung
NL183357B (nl) (2.3-dihydro-2.2-dimethyl-benzofuran-7-yloxy-n-methylcarbamoyl)-(n'-alkylcarbamoyl)-sulfiden, werkwijze voor de bereiding daarvan, werkwijze voor de bereiding van een insecticide preparaat alsmede werkwijze voor de bestrijding van insecten.
IT7825713A0 (it) Derivati d'acido ciclopropancarbossilico, processo per la loro produzione e loro impiego come prodotti per laproduzione d'insetticidi.
NL7500785A (nl) Werkwijze voor de bereiding van nieuwe carbonzu- ren en derivaten daarvan, werkwijze voor de be- reiding van farmaceutische preparaten die deze nieuwe verbindingen bevatten, alsmede farmaceu- tische preparaten verkregen volgens deze werk- wijze.
NL7608874A (nl) Werkwijze voor het maken van een blanko voor een identificatiekaart of dergelijke, alsmede het product van deze werkwijze.
JPS5215894A (en) Process for preparing a substance possessing biological actions
NL177590C (nl) Meertrapswerkwijze voor de bereiding van di-n-propylazijnzuur.
EP0302303A3 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DE68917379D1 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
NL7707510A (nl) Werkwijze ter bereiding van 1-fluor-2-halogeen- -ethylthionofosfor(fosfon)-zuuresters en werk- wijze ter bereiding van insecticide, acaricide en nematicide preparaten daarmee.
NL7702307A (nl) Werkwijze ter bereiding van optisch actieve erythro-15,16-dioxyprosteenzuren en esters daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve componenten om- vatten.
NL181358C (nl) Werkwijze voor de bereiding van 3,6-dichloorpicolinezuur.
NL7609266A (nl) Werkwijze ter bereiding van hydroxyzuren, werk- wijze ter vervaardiging van farmaceutische preparaten hiermede, alsmede de aldus gevormde voortbrengselen.
DD137837A5 (de) Verfahren zur herstellung von zwischenprodukten fuer die synthese von 1,9-dihydroxy-hexahydro-dibenzopyranen
IT1046671B (it) Esteri o feniltionotiolfocedorici processo per la loro produzione e loro impiego come insetticidi e acaricidi
NL7705880A (nl) Werkwijze voor de bereiding van 2.2-dimethyl-3- -(2'.2'-dihalogeenvinyl)-cyclopropaan-1-carbon- zuuresters.
ZA732384B (en) Disubstituted n-(aminomethylidene)-thiol-(thiono)-phosphoric acid ester imides,process for their production and their use as insecticides and acaricides
NL7507827A (nl) Werkwijze ter bereiding van imidazolyl-(thiono)- -fosfor(fosfon) zuuresters respectievelijk -amiden, werkwijze ter bereiding van insecticide, acaricide en nematicide preparaten en gevormde preparaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee